marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
MedTech Acquisition Corporation Balance Sheet 2011-2024 | MTAC
Annual Balance Sheet MedTech Acquisition Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-11.4 M | - | - | -1.33 M | - | - | - | - | - | - | - | - | - |
Long Term Debt |
88 K | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
275 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
14.7 M | 32.4 M | 1.6 M | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
51.7 M | 34.3 M | 17.3 M | 8.85 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-248 M | -186 M | -16.7 M | - | - | - | - | - | - | - | - | - | - |
Total Assets |
25.7 M | 22 M | 251 M | 250 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
11.8 M | 9.41 M | 201 K | 1.33 M | - | - | - | - | - | - | - | - | - |
Book Value |
-25.9 M | -12.3 M | 233 M | 241 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-25.9 M | -176 M | -16.7 M | -21.5 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet MedTech Acquisition Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
21.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
56.6 M | 52.8 M | 51.7 M | 25.1 M | - | - | 34.3 M | 12.2 M | 12 M | 14.3 M | 17.3 M | 20.4 M | 22.7 M | 23.7 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-266 M | -262 M | -248 M | -213 M | - | - | -186 M | -11.7 M | -11.5 M | -13.9 M | -16.7 M | -19.6 M | -21.5 M | -21.9 M | -21.5 M | -21.5 M | -711 K | -711 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
32.4 M | 17.9 M | 25.7 M | 33.6 M | - | - | 22 M | 251 M | 251 M | 250 M | 251 M | 251 M | 251 M | 252 M | 252 M | 252 M | 252 M | 252 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
16.5 M | 3.97 M | 11.8 M | 21.4 M | 4.15 M | 7.02 M | 9.41 M | 12.3 M | 69.2 K | 50.9 K | 201 K | 278 K | 643 K | 1.13 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-24.1 M | -34.9 M | -25.9 M | 8.49 M | - | - | -12.3 M | 239 M | 239 M | 236 M | 233 M | 230 M | 229 M | 228 M | 229 M | 229 M | 229 M | 229 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-24.1 M | -34.9 M | -25.9 M | 8.49 M | -198 M | -184 M | -176 M | -154 M | -11.5 M | -13.9 M | -16.7 M | -19.6 M | -21.5 M | -21.9 M | -21.5 M | -21.5 M | 5 M | 5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency